BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 14, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Photomicrograph of hepatocellular carcinoma

China approves world’s first methylation test for liver cancer

Aug. 9, 2023
By Doris Yu
Laboratory for Advanced Medicine & Health Group (LAMH)’s subsidiary Guangzhou Youze Biotechnology Co. Ltd. received marketing approval in China for its methylation test, which the company says is the first methylation test kit for liver cancer on the market in the world.
Read More

Appointments and advancements for Aug. 9, 2023

Aug. 9, 2023
New hires and promotions in the med-tech industry, including: Nyra Medical, Quanterix, Singular Genomics.
Read More

Financings for Aug. 9, 2023

Aug. 9, 2023
Med-tech firms raising money in public or private financings, including: Diality, Invo Bioscience, Neuraxis.
Read More

In the clinic for August 9, 2023

Aug. 9, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: C2N Diagnostics.
Read More

Regulatory actions for August 9, 2023

Aug. 9, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Curiteva, Theranica Bio-Electronics.
Read More

Other news to note for August 9, 2023

Aug. 9, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anteris, Gedi Cube, Hyperfine, Myriad Genetics, Renovaro, T2 Biosystems.
Read More
Novastep MIS platform

Novastep acquisition puts Enovis on firm footing

Aug. 8, 2023
By Bernard Banga
Enovis Corp. acquired Novastep SAS and its foot and ankle minimally invasive surgical (MIS) platform from Amplitude Surgical SAS for €68 million.
Read More

Financings for Aug. 8, 2023

Aug. 8, 2023
Med-tech firms raising money in public or private financings, including: Figur8.
Read More

Appointments and advancements for Aug. 8, 2023

Aug. 8, 2023
New hires and promotions in the med-tech industry, including: Biophotas, Haemonetics, Heartbeam, Lumabridge, Nyra, Zerigo.
Read More

Other news to note for August 8, 2023

Aug. 8, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agilent Technologies, Corstrata, Dariohealth, Element Biosciences, Fesarius Therapeutics, Health Recovery Solutions.
Read More
Previous 1 2 … 611 612 613 614 615 616 617 618 619 … 10250 10251 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • 3D illustration of a nerve cell

    Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

    BioWorld
    Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
  • Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists

    BioWorld Science
    Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing